Trial
NCT01180569
Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Celgene Corporation
Condition
Lymphoma
Intervention
lenalidomide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-25